Panaxia Labs Israel Stock EBITDA
| HROD Stock | 5,252 499.00 10.50% |
Panaxia Labs Israel fundamentals help investors to digest information that contributes to Panaxia Labs' financial success or failures. It also enables traders to predict the movement of Panaxia Stock. The fundamental analysis module provides a way to measure Panaxia Labs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Panaxia Labs stock.
Panaxia |
Panaxia Labs Israel Company EBITDA Analysis
Panaxia Labs' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Panaxia Labs EBITDA | (15.07 M) |
Most of Panaxia Labs' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Panaxia Labs Israel is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Panaxia Labs Israel reported earnings before interest,tax, depreciation and amortization of (15.07 Million). This is much lower than that of the Other sector and significantly lower than that of the Other industry. The ebitda for all Israel stocks is notably higher than that of the company.
Panaxia EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Panaxia Labs' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Panaxia Labs could also be used in its relative valuation, which is a method of valuing Panaxia Labs by comparing valuation metrics of similar companies.Panaxia Labs is currently under evaluation in ebitda category among its peers.
Panaxia Fundamentals
| EBITDA | (15.07 M) | |||
| Net Income | 2.73 M | |||
| Cash And Equivalents | 2.6 M | |||
| Cash Per Share | 0.83 X | |||
| Total Debt | 13.21 M | |||
| Current Ratio | 2.79 X | |||
| Book Value Per Share | (6.55) X | |||
| Cash Flow From Operations | (1.7 M) | |||
| Earnings Per Share | (0.26) X | |||
| Beta | 1.17 | |||
| Market Capitalization | 57.97 M | |||
| Total Asset | 18.08 M | |||
| Z Score | 2.4 | |||
| Net Asset | 18.08 M |
About Panaxia Labs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Panaxia Labs Israel's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Panaxia Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Panaxia Labs Israel based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Panaxia Stock
Panaxia Labs financial ratios help investors to determine whether Panaxia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Panaxia with respect to the benefits of owning Panaxia Labs security.